Literature DB >> 21531194

Words of wisdom. Re: Salvage therapy with bicalutamide 150 mg in nonmetastatic castration-resistant prostate cancer. Lodde M, Lacombe L, Fradet Y.

Jan Kliment1.   

Abstract

Entities:  

Year:  2011        PMID: 21531194     DOI: 10.1016/j.eururo.2011.03.042

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison.

Authors:  Yun-Fei Li; Shao-Feng Zhang; Tao-Tao Zhang; Lei Li; Wei Gan; Hong-Tao Jia; Sheng Xie; Hui-Hua Ji; Da-Lin He
Journal:  Asian J Androl       Date:  2013-08-19       Impact factor: 3.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.